Autolus Therapeutics (AUTL) Other Working Capital Changes (2018 - 2025)

Autolus Therapeutics (AUTL) has reported Other Working Capital Changes for 5 consecutive years, with $5.4 million the latest figure, recorded in Q4 2025.

• Quarterly Other Working Capital Changes rose 46.05% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.6 million (up 4068.83% YoY) and the FY2025 annual result came in at $14.6 million, up 4068.83% from the prior year.
• Other Working Capital Changes improved to $5.4 million in Q4 2025 per AUTL's latest filing, from $2.6 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for AUTL reached as high as $4.7 million in Q1 2025 and fell as low as -$7.3 million in Q4 2025.
• A 5-year average of -$153100.0 and a median of -$87500.0 in 2021 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes sank 23430.0% — and 2025, when it soared 374.32%.
• Year by year, Other Working Capital Changes stood at -$4.1 million in 2021, then retreated by 2.38% to -$4.2 million in 2022, then surged by 62.28% to -$1.6 million in 2023, then soared by 333.27% to $3.7 million in 2024, then jumped by 46.05% to $5.4 million in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $5.4 million, $2.6 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.